share_log

Teladoc Health | 3: Initial statement of beneficial ownership of securities-Officer Cave James L.

Teladoc Health | 3: Initial statement of beneficial ownership of securities-Officer Cave James L.

Teladoc Health | 3:首次持股聲明-高管 Cave James L.
美股sec公告 ·  05/06 16:10
Moomoo AI 已提取核心訊息
James L. Cave, serving as the Interim Chief Accounting Officer (CAO) of Teladoc Health, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as required by Section 16(a) of the Securities Exchange Act of 1934. The filing, dated 05/04/2024, indicates that Cave beneficially owns 10,448 shares of Teladoc Health's common stock directly. Additionally, the filing details Cave's holdings in derivative securities, including employee stock options and restricted stock units (RSUs) with various vesting schedules and expiration dates extending up to 10/31/2031. The RSUs represent a contingent right to receive shares of Teladoc Health common stock upon vesting. The document was signed by Adam C. Vandervoort, Attorney-in-Fact, on 05/06/2024.
James L. Cave, serving as the Interim Chief Accounting Officer (CAO) of Teladoc Health, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as required by Section 16(a) of the Securities Exchange Act of 1934. The filing, dated 05/04/2024, indicates that Cave beneficially owns 10,448 shares of Teladoc Health's common stock directly. Additionally, the filing details Cave's holdings in derivative securities, including employee stock options and restricted stock units (RSUs) with various vesting schedules and expiration dates extending up to 10/31/2031. The RSUs represent a contingent right to receive shares of Teladoc Health common stock upon vesting. The document was signed by Adam C. Vandervoort, Attorney-in-Fact, on 05/06/2024.
根據1934年《證券交易法》第16(a)條的要求,擔任Teladoc Health, Inc.臨時首席會計官(CAO)的詹姆斯·凱夫已向美國證券交易委員會提交了初步的證券實益所有權聲明。這份日期爲2024年4月5日的文件顯示,凱夫直接實益擁有Teladoc Health的10,448股普通股。此外,該文件詳細介紹了凱夫持有的衍生證券,包括員工股票期權和限制性股票單位(RSU),其各種歸屬時間表和到期日延長至2031年10月31日。限制性股票單位代表在歸屬時獲得Teladoc Health普通股的或有權利。該文件由事實律師亞當·範德沃特於2024年6月5日簽署。
根據1934年《證券交易法》第16(a)條的要求,擔任Teladoc Health, Inc.臨時首席會計官(CAO)的詹姆斯·凱夫已向美國證券交易委員會提交了初步的證券實益所有權聲明。這份日期爲2024年4月5日的文件顯示,凱夫直接實益擁有Teladoc Health的10,448股普通股。此外,該文件詳細介紹了凱夫持有的衍生證券,包括員工股票期權和限制性股票單位(RSU),其各種歸屬時間表和到期日延長至2031年10月31日。限制性股票單位代表在歸屬時獲得Teladoc Health普通股的或有權利。該文件由事實律師亞當·範德沃特於2024年6月5日簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息